| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/01/2004 | WO2004027090A2 Method for differentiating chondrocytes, which are capable of forming an extracellular cartilaginous matrix, from chondrocytes, which do not have this capability, by determining the gene expression status |
| 04/01/2004 | WO2004027089A1 Method for the amplification of genetic information |
| 04/01/2004 | WO2004027088A2 Method for determining the predisposition of patients to toxicity or lack of efficacy of a drug |
| 04/01/2004 | WO2004027087A2 Method of determining specific groups forming heparins |
| 04/01/2004 | WO2004027086A1 Method of detecting meticillin-resistant micro-organisms |
| 04/01/2004 | WO2004027085A1 Adhesive sheet for testing microbe on solid body and kit |
| 04/01/2004 | WO2004027084A1 Detection of biological molecules by differential partitioning of enzyme substrates and products |
| 04/01/2004 | WO2004027083A2 An analyzer for the simultaneous enzymatic detection of closely related analytes |
| 04/01/2004 | WO2004027082A2 Methods and compositions for detecting targets |
| 04/01/2004 | WO2004027081A2 Methods and composition for detecting targets |
| 04/01/2004 | WO2004027080A2 Method of extracting nucleic acids from microbial samples |
| 04/01/2004 | WO2004027079A2 Nuclear factor of activated t cells receptor |
| 04/01/2004 | WO2004027070A2 Transgenic expression cassettes for expressing nucleic acids in non-reproductive flower tissues of plants |
| 04/01/2004 | WO2004027062A2 Functional correction of the -786c/t variance of the human enos gene |
| 04/01/2004 | WO2004027060A1 Method of amplifying nucleic acid, reagent kit for amplifying nucleic acid, method of detecting single nucleotide polymorphism and reagent kit for detecting single nucleotide polymorphism |
| 04/01/2004 | WO2004027059A1 Process for producing ligand binding protein with the use of cell-free protein synthesis system and utilization thereof |
| 04/01/2004 | WO2004027058A1 Method of detecting genes specifying allergy predisposition |
| 04/01/2004 | WO2004027057A1 Method of analyzing organelle-localized protein and materials for analysis |
| 04/01/2004 | WO2004027056A2 Methods of use for thermostable rna ligases |
| 04/01/2004 | WO2004027054A1 Thermostable rna ligase from thermus phage |
| 04/01/2004 | WO2004027046A2 Methods of producing 4-amino-3-mercapto-triazoles |
| 04/01/2004 | WO2004027031A2 Tryptophan hydroxylase assay |
| 04/01/2004 | WO2004027028A2 Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture |
| 04/01/2004 | WO2004027025A2 Helicase dependent amplification of nucleic acids |
| 04/01/2004 | WO2004027024A2 Isolation of genetic molecules from a complex biological construct for use in genetic expression analysis |
| 04/01/2004 | WO2004027023A2 Preservation of rna and reverse transcriptase during automated liquid handling |
| 04/01/2004 | WO2004027021A2 Device and methods for isolating target cells |
| 04/01/2004 | WO2004027020A2 Identification of a phage associated lytic enzyme to rapidly and specifically detect and kill bacillus anthracis |
| 04/01/2004 | WO2004027018A2 Inducible focal adhesion kinase cell assay |
| 04/01/2004 | WO2004026892A2 Fragmentation of dna |
| 04/01/2004 | WO2004026820A2 Method for assaying compounds that decrease the activity of poly(adp-ribose)-polymerase (parp) |
| 04/01/2004 | WO2004026804A1 Anthraquinone quencher dyes, their methods of preparation and use |
| 04/01/2004 | WO2004026458A1 Method for arranging a polymer molecule |
| 04/01/2004 | WO2004026266A2 SYNTHESIS AND APPLICATIONS OF TRINUCLEOTIDE pCpCpA-3′-NH-AMINOACYL DERIVATIVES |
| 04/01/2004 | WO2004026265A2 Compositions and methods for treatment of herpesvirus infections |
| 04/01/2004 | WO2004026260A2 Prophylactic and therapeutic hiv aptamers |
| 04/01/2004 | WO2004026249A2 Methods and compositions for preventing skin damage |
| 04/01/2004 | WO2004026227A2 A METHOD FOR GENERATION OF A RANDOM RNAi LIBRARY AND ITS APPLICATION IN CELL-BASED SCREENS |
| 04/01/2004 | WO2004026120A2 Methods for diagnosing and treating tumors and suppressing cd promoters |
| 04/01/2004 | WO2004026109A2 Molecular targets of cancer and aging |
| 04/01/2004 | WO2004026107A2 Kits and methods for assessing skin health |
| 04/01/2004 | WO2004026026A1 7f4 gene transgenic animal |
| 04/01/2004 | WO2004020675A3 Polymorphism detection among homologous sequences |
| 04/01/2004 | WO2004016766A3 Real time measurement of cellular responses |
| 04/01/2004 | WO2004016759A3 Compositions and methods for induction of proteins involved in xenobiotic metabolism |
| 04/01/2004 | WO2004010103A3 Impedance based devices and methods for use in assays |
| 04/01/2004 | WO2004009803A3 Regulation of human hepsin |
| 04/01/2004 | WO2004009762A9 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 04/01/2004 | WO2004007723A3 Genes |
| 04/01/2004 | WO2004006832A3 Methods and compounds for reducing biofilm formation |
| 04/01/2004 | WO2004005889A3 Detection of drug-resistant human immunodeficiency virus |
| 04/01/2004 | WO2004005881A3 Methods for identification of compounds modulating insulin resistance |
| 04/01/2004 | WO2004005478A3 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 04/01/2004 | WO2004003230A3 Diagnostic method for identifying the biological age of a dna sample |
| 04/01/2004 | WO2003106703A3 Homogenous assay for enzymatic activity |
| 04/01/2004 | WO2003106659A3 Aptamer-toxin molecules and methods for using same |
| 04/01/2004 | WO2003106652A3 Method of haplotype-based genetic analysis for determining risk for developing insulin resistance, coronary artery disease and other phenotypes |
| 04/01/2004 | WO2003106630A3 Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interference |
| 04/01/2004 | WO2003104685A3 Fluorescent entity comprising a fluorophore covalently attached to at least one oligonucleotide and comprising at least one functional group, and uses thereof |
| 04/01/2004 | WO2003100420A3 Electrochemical enzyme immunoassay for simultaneously detecting a number of analytes |
| 04/01/2004 | WO2003100093A3 Method of selecting targets for gene silencing by rna interference |
| 04/01/2004 | WO2003100082A8 Methods of determining precise herg interactions and altering compounds based on said interactions |
| 04/01/2004 | WO2003099780A3 Luminogenic protease substrates |
| 04/01/2004 | WO2003097876A8 Method for improving efficiencies in livestock production |
| 04/01/2004 | WO2003097683A3 Human obesity susceptibility gene and uses thereof |
| 04/01/2004 | WO2003095670A3 Process for generating sequence-specific proteases by directed evolution and use thereof |
| 04/01/2004 | WO2003093492A3 Compositions and methods for determining susceptibility of hepatitis c virus to anti-viral drugs |
| 04/01/2004 | WO2003091381A3 Height-related gene |
| 04/01/2004 | WO2003089609A3 Short fragment homologous replacement to provide bse resistant cattle |
| 04/01/2004 | WO2003088913A3 Peptide deformylase activated prodrugs |
| 04/01/2004 | WO2003087840A3 Protein involved in cancer |
| 04/01/2004 | WO2003087765A3 System for tracing animal products |
| 04/01/2004 | WO2003084540A3 Compositions comprising mmp7 modulators for the treatment of chronic pain |
| 04/01/2004 | WO2003082314A3 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1) |
| 04/01/2004 | WO2003081238A3 Cytocapacity test |
| 04/01/2004 | WO2003080209A3 Method of concentrating macromolecules or agglomerates of molecules or particles |
| 04/01/2004 | WO2003077868A3 Synthesis of synthons for the manufacture of bioactive compounds |
| 04/01/2004 | WO2003075837A3 Internal positive control for probe-based nucleic acid molecule assays and methods of making and using therof |
| 04/01/2004 | WO2003074069A3 Diagnostics and therapeutics for diseases associated with the n-formyl peptide receptor 1 (fpr 1) |
| 04/01/2004 | WO2003072821A3 Method and nucleic acids for the analysis of a colon cell proliferactive disorder |
| 04/01/2004 | WO2003070907A3 Novel fungal lipase |
| 04/01/2004 | WO2003069305A3 Fluorescent phospholipase assay, phospholipase a2 inhibitor and stimulator, and the use thereof |
| 04/01/2004 | WO2003066877A3 Compositions and methods relating to hepatic specific genes and proteins |
| 04/01/2004 | WO2003066827A3 Methods and compositions for detecting differences between nucleic acids |
| 04/01/2004 | WO2003063773A3 Differentially-regulated prostate cancer genes |
| 04/01/2004 | WO2003062418B1 Method and apparatus for detecting nucleic acid data |
| 04/01/2004 | WO2003062270B1 Fluorescent protein from aequorea coerulscens and uses therof |
| 04/01/2004 | WO2003061831A3 Sampling device and method for the simultaneous, quantifiable determination of infectious germs |
| 04/01/2004 | WO2003060100A3 CRYSTALLIZED DnaG PRIMASE COMPLEXES AND METHODS OF USE THEREOF |
| 04/01/2004 | WO2003060090A3 Novel cytokine zcytor17 ligand |
| 04/01/2004 | WO2003057913A3 Method for the detection and/or identification of the original animal species in animal matter contained in a sample |
| 04/01/2004 | WO2003056029A3 Highly sensitive and continuous protein-tyrosine-phosphatase (ptpase) test using 6,8 difluoro-4-methyl-umbelliferylphosphate |
| 04/01/2004 | WO2003054226A3 Methods of treating psychosis and schizophrenia based on a polymorphism in the ctf gene |
| 04/01/2004 | WO2003052376A3 Method and apparatus for dna collection |
| 04/01/2004 | WO2003050243A3 Novel genes encoding colon cancer antigens |
| 04/01/2004 | WO2003046214A3 Method for analyzing translation-controlled gene expression |
| 04/01/2004 | WO2003046201A3 Detection and identification of enteric bacteria |
| 04/01/2004 | WO2003040670A3 Method of identifying energy transfer sensors for analytes |
| 04/01/2004 | WO2003039703A3 Method in the form of a dry rapid test for detecting nucleic acids |
| 04/01/2004 | WO2003034064A3 Image analysis of high-density synthetic dna microarrays |